Phummarin Suphankhul

Therapeutic Area Medical Lead (Lung, Gastrointestinal, Genitourinary, Gynecological, Breast Cancer & Diagnostics)
2020–Present

Plan 100 GI Cancer lead in Asia ( Extend role)

2025

Medical Science Liaison (MSL)
2017–2020

IMPACT & ACHIEVEMENTS

Strategic Leadership & Regional Expansion

• Appointed lead for GI Cancer business expansion in Asia (2025), directing cross-country launch readiness, regional evidence generation, and leadership of Asia-wide medical initiatives.
• Coordinated multi-country best practice sharing, scientific conferences, and publication strategy in alignment with international standards.

Evidence Generation & Policy Change

• Drove successful initiation of the EARLY study, resulting in Thai government endorsement of AI-powered chest X-ray in national lung cancer screening programs.
• Championed the i-RETRO study, transforming the classification and diagnosis of HER2 breast cancer in Thailand.
• Led real-world evidence projects supporting reimbursement and policy change, including Durvalumab in stage III NSCLC and Thailand’s first BRCA registry.

Partnerships & Innovation

• Forged strategic partnerships with AI providers, medical societies, and patient advocacy groups to implement sustainable national lung cancer screening with AI-assisted CXR.
• Established diagnostic readiness initiatives with Siriraj Genomics, enabling early market authorization for ovarian and breast cancer therapies.

Cross-Functional Collaboration

• Collaborated extensively with commercial, market access, and regulatory teams to secure reimbursement for Durvalumab and advance launch preparedness across tumor types.
• Played integral role in clinical guideline development, RWE studies, and early access programs.

Leadership & Capability Development

• Supervised and mentored Medical Advisors, MSLs, and Diagnostics Leads; contributed to talent development with promotions of two MSLs and one Dx Lead in 2024.
• Built robust medical teams aligning local execution with regional and global medical strategies.

Diagnostic Team Establishment ( Lung ,Breast , Ovarian and Breast cancer)

• Oversaw project planning and execution , enhancing molecular diagnostic capabilities and integrating innovative technologies to support precision medicine across the region. Enabled diagnostic readiness for market adoption, contributing to improved patient stratification and clinical decision-making.
• Set up diagnosis team in AstraZeneca

RECOGNITION & AWARDS

• 2024: Three CP Awards – Unlocking PACIFIC reimbursement access, delivering patient-centric solutions (Thailand Bold Journey), and Accelerate Expansion via HIMALAYA launch.
• 2023: CP Award – Initiated laboratory partnerships to advance local HRD testing for oncology diagnostics.
• 2022: CP Award – Established public-private partnership for lung cancer AI screening and raised national awareness.

• Promoted oncology brands (Alimta, Gemzar, Cyramza) for multiple cancers and managed pre-launch activities and hospital listing.
• Served as brand champion, mentor, and company representative in regional contests.
• Achieved Top Sales Award (2012) and Brand Champion Award (2013).

Assistant Product Manager : Jan 2010 - July 2010

Medical Representative : Apr 2008 - Dec 2009

• Collaborated with cross-functional teams to ensure smooth product rollouts and successful launch of woman healthcare product
• Assisted in establishing pricing strategies, ensuring competitiveness within the market while maintaining profitability goals.
• Contributed to the development of training programs for both internal staff and external partners, promoting a thorough understanding of product functionality.
• Presented detailed reports on product performance metrics to senior management, identifying areas for growth and opportunities for optimization.

• Verified safety and accuracy of physician orders.
• Dispensed and procured medicinal products and supplies used in hospital.
• Developed effective relationships with physicians, nurses, and other healthcare professionals to ensure optimal communication and collaboration in patient care.
• Provided accurate drug information to healthcare providers on the safe use of medications within the hospital setting.